Chari A, Stewart AK, Russell SD, et al. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood advances. 2018, 2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.
Advertisement
Articles by Chari A, Stewart AK, Russell SD, et al. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood advances. 2018, 2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
2
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
3
US Employer Health Care Costs Projected to Rise 9.5% in 2027
4
MRI Shows Hypothalamic Atrophy in Narcolepsy Type 1, Sparing Subregion
5